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ABSTRACT 
Cytosine methylation at CpGs contributes to the epigenetic maintenance of gene silencing. 
Dynamic reprogramming of DNA methylation patterns is believed to play a key role during 
development and differentiation in vertebrates. The mechanisms of DNA demethylation 
remain unclear and controversial. Here, we present the first detailed characterization of the 
demethylation of an endogenous gene in cultured cells. This is triggered in a regulatory region 
by a transcriptional activator, the glucocorticoid receptor. We show that DNA demethylation 
is an active process, occurring independently of DNA replication, and in a distributive manner 
without concerted demethylation of cytosines on both strands. We demonstrate that the DNA 
backbone is cleaved 3’ to the methyl-cytidine during demethylation, and suggest that a DNA 
repair pathway may therefore be involved in this demethylation. 
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INTRODUCTION 
In vertebrates, DNA methylation occurs at the carbon-5 position of cytosine in the 
dinucleotide CpG. This DNA modification is involved in stabilizing the silent state of genes, 
either by locally preventing regulators from binding to their target or by recruiting specific 
proteins that favor the formation of silent chromatin (1, 2). DNA methylation participates in 
the control of several aspects of mammalian development, including X chromosome 
inactivation, parental imprinting and tissue-specific expression of genes (1, 2). Alterations in 
the methylation patterns of a number of genes are believed to be involved in both the 
initiation and the progression of cancer (3, 4). 
The propagation of the methylated state through DNA replication is ensured by the action of 
maintenance and de novo DNA methyltransferases (DNMTs) (1, 5, 6). DNA methylation is 
subject to regulated reprogramming, in particular during development (1, 7, 8). Genome-wide 
waves of demethylation and remethylation are observed during gametogenesis and after 
fertilization. Localized DNA demethylation occurs later at specific genes, mostly when and 
where differentiation requires their activation. Although maintenance and de novo 
methylation are relatively well understood, the mechanisms of DNA demethylation are still 
unclear and controversial (1, 6, 9, 10). Two distinct mechanisms have been shown to act 
during the genome-wide demethylation occurring after fertilization in mouse : a passive 
mechanism resulting from the absence of maintenance methylation following replication is 
responsible for the demethylation of the maternal genome (11), whereas an active mechanism 
of unknown nature appears to be responsible for the demethylation of the paternal genome 
(7). The mechanisms of local gene-specific demethylation are also unclear (9). Passive and 
active demethylation, and a combination of the two, have all been proposed to occur in 
various local events analyzed (12-15). 
Several attempts have been made to characterize the mechanism of DNA demethylation in 
vitro (reviewed in 9). Three classes of mechanisms have been proposed: direct removal of the 
methyl moiety from the base, excision of the methylated base, and excision of the methylated 
nucleotide. These pathways were supported by the identification of corresponding enzymatic 
activities (16), but these demethylases have failed to gain widespread acceptance due to the 
lack of reproducibility of the data and to the caveats in the experimental approaches used (17, 
18). It is thus essential to firmly establish the nature of the biochemical pathways of MeCpG 
demethylation in live cells. 
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To study the mechanisms of local targeted DNA demethylation in living cells, we have 
investigated an enhancer-specific demethylation event at an endogenous gene, triggered by a 
transcriptional activator during development. We analyzed the demethylation occurring at a 
glucocorticoid-responsive unit (GRU) located 2.5 kb upstream from the transcription start site 
of the tyrosine aminotransferase (Tat) gene upon activation by the glucocorticoid receptor. 
This event takes place in the liver prior to birth and is involved in the memorization of the 
first stimulation of the gene by glucocorticoids (19). We demonstrate that demethylation of 
cytosines at this gene under physiological conditions results from an active mechanism that 
involves the creation of nicks in the DNA 3’ to the methylcytidine. This would be consistent 
with the involvement of a demethylase initiating a base or nucleotide excision repair. 
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RESULTS 
Demethylation of the Tat gene enhancer does not require passage through S phase 
DNA demethylation of the Tat enhancer can be triggered ex vivo by glucocorticoid treatment 
of either cultured e.d.15 fetal hepatocytes or a rat hepatoma cell line (H4IIEC3). The 
glucocorticoid receptor (GR) induces a chromatin-remodeling event over the 450 bp that 
encompass the four demethylated CpGs (20). This chromatin remodeling is rapid (15 min-
1 hour), and reversible following hormone withdrawal. In contrast, DNA demethylation is 
slow and persists in non-stimulated cells (19). 
Three of the four MeCpGs that are demethylated are clustered within a 15 bp region (Fig 1 A). 
The features of the demethylation kinetics of these MeCpGs are best seen by ligation mediated 
PCR (LM-PCR) analysis of genomic DNA treated with hydrazine and piperidine under 
conditions where DNA is cleaved only at unmethylated cytosines (Fig. 1 B). In hepatoma 
cells, the three Cs were all demethylated slowly. Demethylation was detectable after a few 
hours of stimulation and proceeded steadily over a 24-hour time period. The relatively slow 
kinetics of methylation loss seems consistent with a passive mechanism, but the different rates 
observed for neighboring Cs on the same strand (compare U2 with U1 and U3 on Fig. 1) 
suggests rather that demethylation is not the mere consequence of the absence of maintenance 
methylation following DNA replication. The slow kinetics might reflect a more subtle 
connection between DNA replication and demethylation or that a passage through a specific 
phase of the cell cycle is required for another reason.. 
Arresting cell growth at particular phases of the cell cycle by means of drugs and/or specific 
culture conditions was not a suitable procedure for the investigation of a putative role of DNA 
replication in DNA demethylation, since the activation of the Tat gene by GR was affected by 
these treatments, independently of the DNA methylation status of the GRU (data not shown 
and 21). In growing cells, however, the Tat gene can be activated throughout the cell cycle 
except during mitosis (21). Cells released from a treatment inducing a cell cycle arrest resume 
growth synchronously and regain their capacity to respond normally to glucocorticoids (data 
not shown). They are therefore well suited for the study of the demethylation mechanism of 
the Tat gene without any interference that might be caused by the continued presence of 
drugs. To determine rigorously whether passage through a specific phase of the cell cycle was 
important for demethylation, we compared asynchronously and synchronously growing cells. 
Since LM-PCR analysis of hydrazine-piperidine treated DNA cannot be used for precise 
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quantification, we used MethylQuant, a novel real-time PCR approach for quantifying the 
methylation status of a single cytosine (22), to measure the demethylation rate. Bisulfite-
treated genomic DNA was PCR amplified, and the methylation status of a specific cytosine 
was quantified by real-time PCR by using a primer whose 3’-end discriminates for the 
methylation status of the cytosine of interest. Figure 2 shows the quantification of the 
methylation status of U3 that has an intermediate demethylation rate as shown in Figure 1. 
Within an asynchronous population not stimulated by glucocorticoids, the level of 
unmethylation for each position is 2-10%, due to the presence of unmethylated cytosines 
scattered amongst the Tat GRU molecules (vide infra). The proportion of unmethylated U3 
cytosines did not change during the first 6 hours of glucocorticoid treatment but, after this lag 
and during the next 18 hours, it steadily increased to reach 85%. The rapid demethylation of 
70% of the cytosines that occurred between 6 and 24 hours argues against a purely passive 
demethylation mechanism, since the cells had a doubling time of about 24 hours in the 
conditions used here, and thus underwent, at most, a single replication event during this 
period. 
To find out if passive demethylation was nevertheless involved, in combination with active 
demethylation, i.e. whether there was active demethylation of the hemimethylated cytosines 
produced upon replication, we analyzed the possibility that demethylation occurs 
preferentially during S phase. Cells were synchronized at the beginning of S phase by 
aphidicolin treatment and then released from the block in the presence of glucocorticoids. A 
6-hour time lag was again found before any demethylation was observed (Fig. 2), and 
consequently no detectable loss of methylation occurred during S phase, revealing that 
maintenance methylation occurred normally at this stage. Demethylation was detected at 8 
hours when the majority of the cells had completed S phase and steadily proceeded thereafter 
for the next 16 hours, during G2 and the following G1, before most of the cells had initiated 
their next S phase. Thus, there was no evidence of a preferential demethylation of 
hemimethylated CpGs resulting from replication: demethylation began with an active 
mechanism on fully methylated CpGs. The rate of demethylation was similar in non-
synchronized and synchronized cells, although the start of demethylation in the latter was 
slightly retarded, probably due to passage through mitosis. We also observed that it was 
possible for demethylation to occur during S phase, since the demethylation rate was not 
slowed down by the entry into S phase of cell populations synchronized and treated with 
glucocorticoid in G1 (data not shown). Quantitative analyses of demethylation at positions 1 
and 2, which were demethylated faster or slower than U3 also revealed that demethylation can 
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occur outside the S phase (vide infra and data not shown). This conclusion is also supported 
by the observation that demethylation of these three Cs occurred in aphidicolin-treated cells 
even though the drug decreased the efficiency of both glucocorticoid induction and DNA 
demethylation (data not shown). In conclusion, demethylation appears to occur at all phases 
of the cell cycle permissive for Tat gene activation, with no preferential phase, and is 
accomplished mainly by an active mechanism. 
Distributive nature of cytosine demethylation in the Tat GRU 
We next assessed whether demethylation of the four MeCpGs occurred through a processive or 
a distributive mechanism in living cells, i.e., whether the various Cs of individual Tat gene 
molecules, in particular 2 Cs belonging to the same CpG, are demethylated in a concerted 
fashion. To this end, we used hairpin-bisulfite PCR which allows simultaneous analysis of the 
two strands of a DNA molecule (5). A hairpin linker, targeted and ligated to restriction-
enzyme-cleaved genomic DNA, prevents the strand separation that occurs upon subsequent 
bisulfite conversion and PCR amplification. Single PCR molecules corresponding to the two 
linked strands are then cloned and sequenced. We applied this method to DNA samples 
prepared from synchronized cells undergoing demethylation, and focused on the cells that had 
not yet undergone demethylation (0 hour time point) and on those that were undergoing active 
demethylation after the end of S and during G1 (10 and 16 hour time points). The various 
methylation patterns of the four CpGs of the Tat GRU, and their frequencies, show that during 
the demethylation process there is no bimodal distribution of fully demethylated and fully 
methylated molecules (Fig. 3). The Cs were demethylated progressively in a rather stochastic 
manner, resulting in molecules with a demethylation level ranging from 0 to 7 demethylated 
Cs. The frequency of molecules with multiple unmethylated positions increased with the 
duration of glucocorticoid stimulation. The different Cs were not all demethylated at the same 
rate, even though similar rates were observed for Cs belonging to the same CpG (Fig. 3 B). 
The demethylation of CpG #1 was the most rapid, whereas that of CpG #4 was the slowest. 
For most positions, extensive demethylation occurred between 10 and 16 hours, when most of 
the cells were outside S phase, further demonstrating the replication-independent nature of 
this demethylation event. 
When the frequencies of demethylated Cs found at each position in either hemimethylated or 
fully demethylated CpGs were compared, there appeared to be a bias in favor of fully 
demethylated CpGs, except for CpG #4 where hardly any demethylation was detectable at U4, 
even when demethylation of L4 was above 20%. (Fig. 3 B). This bias in favor of fully 
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demethylated CpG could have been due to a preferential demethylation of hemimethylated 
CpG, but statistical analyses revealed, however, that it mainly reflected the presence of a 
population of slowly demethylating cells (Supplementary Fig. 1), presumably those refractory 
to induction during mitosis (21). There was only a slight preferential demethylation of a MeC 
facing a demethylated C and no preferential demethylation of neighboring Cs. Overall, 
demethylation appeared to proceed in a distributive manner, essentially with independent 
demethylation of Cs. 
Cytosine demethylation is associated with cleavage of the DNA backbone 
In cultured e.d.15 fetal hepatocytes, glucocorticoid-dependent DNA demethylation of the Tat 
enhancer was similar to that of hepatoma cells but there were some distinctive features: rapid 
demethylation was observed in the first 5 hours following hormonal activation and the various 
Cs were demethylated at similar rates (Fig. 4 A). After 5 hours, however, demethylation did 
not progress any further, since the demethylation levels reached 10 and 24 hours after 
glucocorticoid addition were similar. Presumably, only a subpopulation of the Tat gene 
enhancer responded to glucocorticoids, since the fraction of chromatin that became accessible 
to restriction enzyme cleavage was about 3-4 fold lower in e.d.15 fetal hepatocytes than in 
hepatoma cells (compare Fig 7 in 19 with Fig 1 in 20). Thus, demethylation occurred rapidly 
in the fraction of responsive enhancer, which prompted us to test whether this rapidity would 
make fetal hepatocytes a valuable system for revealing the properties of the active 
demethylation observed in hepatoma cells. 
Since some of the cytosine demethylase activities that have been previously proposed involve 
base or nucleotide excision, we wished to assess whether glucocorticoid treatment induced 
DNA backbone cleavage within the Tat GRU when it underwent demethylation. To this end, 
we used the same LM-PCR procedure that we had used to analyze hydrazine-piperidine 
cleaved genomic DNA, except that we performed it directly on the genomic DNA, without 
any prior treatment. In LM-PCR, a DNA linker is ligated to free 5’-P ends available within 
the region of interest without prior knowledge of their distribution, PCR amplification is then 
performed with the linker and a gene-specific primer and, after a few further rounds of PCR 
amplification with a labeled nested gene-specific primer, the amplified products can be 
detected on a gel (23). PCR amplification generally reaches a plateau in conditions allowing 
detection of minor cleavage products and the same overall plateau is reached for different 
initial numbers of molecules. Thus, specific cleavage products show up if they have a discrete 
distribution, and if they are more abundant than the background cleavages that occur during 
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DNA preparation and that give rise to products distributed throughout the amplified region 
(23). In this way, we could detect glucocorticoid-induced cleavage products within the Tat 
GRU while it was undergoing demethylation, i.e., after 5 hours of dexamethasone treatment 
(Fig. 4 B-C). The corresponding bands were seen on both strands at specific positions above a 
background of widely distributed bands. These bands were not visible after a 24-hour 
dexamethasone treatment when demethylation was completed (Fig. 4 B), but could already be 
detected 3 hours after hormone addition (data not shown). No cleavages above background 
were detectable at CpGs that were not demethylated upon glucocorticoid treatment, such as 
those in the vicinity of the Tat GRU (Fig 4 D). 
To estimate the proportion of gene copies that were giving rise to the cleavage products 
detected, we performed competitive LM-PCR by mixing a fixed amount of genomic DNA 
from fetal hepatocytes treated for 5 hours with dexamethasone with varying amounts of 
restriction enzyme digested rat genomic DNA and then analyzing the mixture by LM-PCR 
(Fig. 4 E). The genomic DNA competed for the detection of the three cleavage products up to 
the 1/625th dilution showing that about one gene copy out of a thousand presented a specific 
cleavage. This is consistent with a short half-life intermediate produced during the 
demethylation process. Registration with the genomic sequencing ladders revealed that the 
glucocorticoid-induced strand breaks affected every MeCpG undergoing demethylation, and 
were located 3’ to the methyl-cytidine, yielding fragments whose 5’-end corresponds to the 
guanosine of the dinucleotide CpG (Fig 4 F). Phosphorylation of these 5’-ends is required for 
linker ligation allowing LM-PCR amplification, and thus the strand breaks detected here had a 
5’-P-end. Any other types of demethylation intermediates, if they exist, would have escaped 
the detection. These breaks were detected on both strands, but they were distributed on 
different DNA molecules, since they were not detected with the linker ligation strategies that 
allow analysis of double-stranded breaks with either blunt or staggered ends (24; data not 
shown). This is consistent with the distributive nature of demethylation. We did not detect any 
glucocorticoid-induced specific strand breaks above background in hepatoma cells despite 
evidence of an active demethylation in these cells. Since the demethylation occurring in 
hepatoma cells was slower than in fetal hepatocytes, it is likely that there were fewer 
demethylation events per unit of time, and, therefore, the number of demethylation 
intermediates produced might have been too low to show up against background cleavages. 
Alternatively, a faster repair of the cleavage products in the hepatoma cells could also have 
precluded their detection. In conclusion, during demethylation of cytosines, the DNA 
backbone was cleaved 3’ to the modified nucleotide. 
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DISCUSSION 
DNA demethylation mechanism 
The demethylation event that we have described here differs from those that have previously 
been described in vertebrates based on biochemical analyses. The cleavage product 3’ to the 
methyl-cytidine is not compatible with an activity that directly removes the methyl group and 
leaves the base intact (16, see Fig. 5 A). It indicates the involvement of a mechanism 
producing DNA strand breaks, and suggests that the methylated base is processed by a base 
lesion repair pathway. Nucleotide excision repair of the MeC would be compatible with the 
cleavage observed, but there is no evidence in favor of such a mechanism, since the only 
demethylating nuclease activity reported so far excises the dinucleotide MeCpG (25, see 
Fig. 5 A). Base excision repair initiated by a MeC glycosylase could also lead to the 3’ 
cleavage (Fig. 5 B-C). Bifunctional glycosylase/lyases couple base excision (DNA 
glycosylase activity) with 3’-phosphodiester bond breakage (DNA nicking activity) leaving a 
5’-P end 3’ to the excised methyl-cytidine, i.e., the type of ends we detected with LM-PCR 
(Fig. 5 C). Monofunctional enzymes do not have this nicking activity, but a transient 5’-P end 
3’ to the MeC is also produced during the short-patch repair of the abasic lesion (Fig. 5 B). 
Hydrolysis of abasic sites before the ligation step of LM-PCR, which may occur during DNA 
purification and denaturation prior to LM-PCR first extension step, would also give 5’-P ends 
3’ to the MeC. Thus, both mono- and bifunctional DNA glycosylases are compatible with the 
cleavage products detected. 
Putative DNA demethylases 
Two monofunctional glycosylases involved in thymine excision in T:G base pairs, TDG and 
MBD4, have been proposed to be active on MeC (26, 27) but these data obtained in vitro have 
not been reproduced in other studies (28, 29), and could have been due to deamination of 
some of the MeC within the substrates used, which would have created unappreciated G/T 
mismatches (9). A demethylation pathway involving deamination of the MeC by cytidine 
deaminases followed by DNA repair of the T:G mismatch has also been suggested to exist 
(30). The involvement of TDG in DNA demethylation was investigated in cultured cells. In 
one study, over-expression of TDG led to DNA demethylation of a retinoic acid receptor 
(RAR) target gene, but surprisingly it was observed in the absence of RAR activation (31). In 
a second study, inhibition of TDG by antisense oligonucleotides interfered with the transient 
demethylation of repetitive sequences that was observed upon myoblast differentiation (32). 
TDG, however, has a coactivator activity that is independent from its glycosylase activity and 
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it participates, with the coactivator p300/CBP, in the transactivation of various target genes 
(33, 34). Thus, the effect exerted by TDG on DNA demethylation might have been indirect 
and have resulted from its transcriptional activation properties. MBD4-/- mice do not show any 
developmental defects suggestive of perturbed DNA demethylation, but rather show an 
increase in the frequency of C->T transitions at CpGs consistent with a role in DNA repair 
(35). Hence, in the absence of solid and reproducible biochemical evidence, or of well 
controlled genetic experiments showing a glycosylase-dependent involvement of TDG or 
MBD4 in DNA demethylation, it is not clear whether these enzymes are good candidates for 
this demethylation process. Furthermore, TDG and MBD4 have been proposed to act 
preferentially on hemimethylated CpGs (26, 27), but we observed that active DNA 
demethylation occurred on symmetrically methylated DNA and did not show a significant 
preference for generating symmetrically demethylated CpGs. In plants, two DNA 
glycosylase-lyases, ROS1 and DEMETER, antagonize the repression exerted by DNA 
methylation (36, 37). DEMETER has just been shown to remove MeC in vivo and in vitro (37) 
and, in contrast to TDG, its DNA glycosylase activity is required for activation of gene 
expression (38). Our results suggest that similar activities are also involved in DNA 
demethylation in vertebrates and revive the need to clarify the connections between DNA 
repair and demethylation. These activities could be targeted to specific regulatory sequences 
either directly through interaction with one of the transcription factors binding these 
sequences, or indirectly through transcription factor-induced chromatin remodeling (9). 
Prevention of double-strand breaks during DNA demethylation 
Since DNA demethylation occurs through a mechanism inducing strand cleavage, there is a 
risk that double-stranded breaks might appear, because multiple modified bases are often 
found in proximity. Previous characterizations of demethylation events taking place in cells 
suggested that a coupling of replication-dependent and active demethylation (14), or a slow 
two-step active mechanism producing hemimethylated sites first (12), could prevent the 
generation of these detrimental DNA damages. We have not found any evidence of such a 
two-step mechanism. Demethylation of MeCpGs occurred on both strands independently from 
replication through an active mechanism affecting fully methylated CpGs, and the various Cs 
were not first hemimethylated all together before being fully demethylated in a clear two-step 
manner. The two-step demethylation observed previously might be the consequence of the use 
of transgenes as demethylation substrates. Indeed, they may not undergo the same regulation 
of methylation patterns as the endogenous gene that we studied in its natural chromatin 
context, particulary in the case of chromatin organization dependent modifications. Tat GRU 
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demethylation seems rather slow and is not processive, and these features might minimize the 
risk of double-stranded breaks. But does such a mechanism perform the demethylation of the 
paternal genome occurring in the mouse egg following fertilization (7), which is rapid, 
replication-independent and affects numerous fully methylated CpGs? A mechanism 
introducing a large number of DNA strand breaks would bear the risk of damaging genome 
integrity and, indeed, we obtained no evidence of extensive cytidine incorporation at this 
developmental stage. This raises the possibility that there are several active mechanisms of 
cytosine demethylation operating at different stages in development. 
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MATERIAL AND METHODS 
Cell synchronization 
We used a subclone of the rat hepatoma cell line (H4IIEC3). Cells were presynchronized in 
G1 by a 30 hour incubation in Coon’s modified Ham-F12 medium without isoleucine in the 
presence of 0.5% FCS. They were then synchronized as follows: The medium was replaced 
by isoleucine-containing medium supplemented with 5% FCS and 5 µg/ml aphidicolin and 
cells were cultured for 18 hours. Cells were then released from the S phase block in 
aphidicolin-free medium supplemented with 10-7 M dexamethasone. They were then collected 
at regular intervals by trypsinization and genomic DNA was purified using the Wizard 
Genomic DNA purification kit (Promega). For cytometry analysis, cells were fixed in ice-
cooled 70% ethanol, washed with PBS and incubated at 37°C for 30 min in 500 µl of PBS 
containing RNAase (100 µg/ml) and propidium iodide (50 µg/ml). Analyses of at least 10,000 
cells were performed with a Coulter Elite-ESP flow cytometer (Beckman-Coulter) using a 15 
mW air cooled argon-ion laser tuned at 488 nm and fluorescence was measured through a 620 
nm band-pass filter. Cell doublets were eliminated on the basis of DNA peak vs. DNA area 
signals and cell cycle quantified with the Multicycle software (Phoenix Flow Systems, San 
Diego, CA). 
Methylation analysis 
Hydrazine-piperidine-LM-PCR analysis was performed as described previously (39). Briefly, 
following chemical treatment, genomic DNA was denatured and a gene-specific primer was 
extended to create blunt-ends suitable for linker ligation allowing subsequent LM-PCR 
amplification (Supplementary Fig. 2). 
We quantified the methylation level of individual cytosines using MethylQuant (22). 
Genomic DNA was treated with sodium bisulfite and the converted upper strand was PCR 
amplified as described. Real-time PCR quantification of the total amplified product and of the 
subpopulation corresponding to the specific methylation status of the cytosine of interest was 
performed by using, respectively, the non-discriminative (ND) and the discriminative (D) 
primer sets designed for the analysis of the U3 cytosine (22). 
Hairpin-bisulfite PCR was adapted to the -2.5 Tat GRU from the protocol described 
previously (5). We ligated the two strands of the GRU using a hairpin linker 
(5’P-AAAGAGCGATGCGTTCGAGCATCGCT) that was compatible with the ends 
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resulting from cleavage at the -2,302 BsmA I site. Bisulfite conversion was carried out as 
described (39), except that the incubation was performed in a PCR machine with slow ramp 
temperatures: 3x (98°C for 1 sec, 50°C for 5 min); 3x (98°C for 1 sec, 50°C for 10 min); 3x 
(98°C for 1 sec, 50°C for 20 min); 3x (98°C for 1 sec, 50°C for 40 min). PCR amplification of 
the -2.5 Tat GRU was performed in TMAC-containing buffer (39) with the following primers: 
TTTGTTGTATAGGATGTTTTAGT and CCAAAATTTACCAATCTCTACTA. Amplified 
DNA was cloned in pGEM-T Easy vector (Promega). 
DNA strand cleavage analysis 
Rat fetal (e.d.15) hepatocytes were isolated and cultured as described (19) except that the non-
adhering hematopoietic cells were removed 16 h after plating. Genomic DNA was analyzed 
by LM-PCR as described (24, 39). LM-PCR was performed to map the 5’-P ends of DNA 
molecules, which were cleaved on at least one strand during the demethylation process as 
follows: DNA was denatured and a gene-specific primer was extended to create blunt-ends 
allowing linker ligation (Supplementary Fig. 2). 
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LEGENDS TO FIGURES 
 
Figure 1: Kinetics of glucocorticoid-induced DNA demethylation at the -2.5 Tat GRU in 
hepatoma cells. (A) The four MeCpGs within the Tat GRU (–2425 to –2336) that are 
demethylated upon glucocorticoid treatment are numbered from 1 to 4 (upper strand: U1 to 
U4, lower strand: L1 to L4). (B) Demethylation kinetics of the three neighboring Cs of the 
upper strand. Rat hepatoma cells were grown with 10-7 M dexamethasone (+Dex) for the 
indicated time. The corresponding genomic DNA was treated with hydrazine and piperidine, 
and analyzed by LM-PCR (19, 40, Supplementary Fig. 2). Genomic DNA cleaved at A+G 
and C+T was analyzed simultaneously. 
 
 
Figure 2: Demethylation of the -2.5 Tat GRU is not restricted to a particular phase of the cell 
cycle. Hepatoma cells were synchronized in early S phase in two steps. They were first 
presynchronised in G1 by isoleucine and serum deprivation and then released from this block 
in the presence of aphidicolin. They were then released from the early S block in the presence 
of 10-7M dexamethasone for the indicated time (0h, arrested cells). The demethylation 
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kinetics in non-synchronized cells was analyzed in parallel. The upper panel shows the 
proportion of unmethylated U3 during glucocorticoid treatment as determined using the 
MethylQuant assay (22). The lower panel shows the proportion of cells in the various phases 
of the cell cycle in the synchronized culture (determined using propidium iodide staining and 
flow cytometry) and the deduced time frames of the phases of the cell cycle. 
 
 
Figure 3: Distribution of the unmethylated cytosines during demethylation of the -2.5 Tat 
GRU. Methylation patterns of individual double-stranded molecules were assessed using the 
hairpin-bisulfite PCR method (5). DNA from the synchronized cells described in Figure 2 was 
analyzed 0, 10 and 16 hours after release from the aphidicolin block in the presence of 
dexamethasone (Dex). (A) Frequencies of the various methylation patterns obtained during 
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demethylation of the -2.5 Tat GRU. The patterns are represented by a succession of circles 
symbolizing the methylation status of cytosines U1/L1, U2/L2, U3/L3, U4/L4, filled: 
methylated, empty: unmethylated. The patterns are organized in subgroups according to the 
number of unmethylated Cs as indicated on the left. The frequency of each pattern is indicated 
(%). As the total numbers of clones analyzed were 43, 77 and 54 for the dexamethasone 
treatments of 0, 10 and 16 hours respectively, the frequencies corresponding to one event are 
2.3, 1.3 and 1.85%, respectively. (B) Time course of the demethylation of each individual 
cytosine. The percentages of unmethylated cytosines, belonging to either hemimethylated or 
fully demethylated CpGs as indicated, are plotted for the three analyzed times of 
dexamethasone induction.  
 
 
Figure 4. DNA is cleaved 3’ to the methylated cytosines during glucocorticoid-induced 
demethylation. Hepatocytes isolated from e.d.15 fetuses were cultured for the indicated time 
(hours) without (control or -) or with (+Dex) 10-7 M dexamethasone. (A) Kinetics of 
glucocorticoid-induced DNA demethylation in hepatocytes analyzed by LM-PCR using 
genomic DNA treated with hydrazine-piperidine as described in Fig. 1 B. (B) Native genomic 
DNA was analyzed by LM-PCR to visualize strand breaks in the upper strand of the -2.5 Tat 
GRU. The arrows indicate the bands revealing cleavage at MeCpG. (C) Analysis of the lower 
strand as in B. (D) Analysis of the upper strand in an upstream region where there are two 
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MeCpGs that are not demethylated. The arrows indicate the location of the corresponding Cs. 
(E) Competitive PCR analysis of the abundance of the glucocorticoid-induced cleavage 
products. A fixed amount of genomic DNA from fetal hepatocytes treated for 5 hours with 
dexamethasone was diluted with varying amounts of rat genomic DNA digested with AvaII 
that cleaves just upstream the -2.5 Tat GRU and analyzed by LM-PCR. The relative amount 
of the competing liver DNA corresponded to either the same amount (1/1) or serial 5-fold 
dilutions (1/5 to 1/625). The regions of the gel showing the bands corresponding to the AvaII 
cleavages and the dexamethasone-induced cleavages at the MeCpG are shown. (F) 
Representation of the location of the strand break detected relative to the CpG dinucleotide. 
Note that LM-PCR allows only analysis of the fragment downstream the break, and thus that 
the location and nature of the 3’-end of the upstream fragment (represented in gray) cannot be 
assessed. 
 
 
Figure 5. Scheme depicting the possible DNA demethylation pathways. (A) Location of the 
cleavages expected for the published putative demethylation mechanisms. The curved arrows 
indicate the cleavages expected for the methyl excision pathway (16), the base excision 
pathway (26), and the dinucleotide excision pathway (25). The cleavage observed herein is 
indicated by the arrow labeled with an asterisk. (B)  The short patch repair pathway involving 
a monofunctional DNA glycosylase that could generate the cleavage product observed (41). 
(C) The action of a bifunctional DNA glycosylase/AP lyase that could generate the cleavage 
product observed (41). The opening of the sugar ring that normally occurs has not been 
represented. 
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LEGENDS TO SUPPLEMENTARY FIGURES 
 
 
Supplementary Figure 1: Estimation of the distributive or processive nature of CpG 
demethylation at the GRU.  
To test whether the bias in favor of fully demethylated CpG seen in Fig. 3 B could be due 
either to a preferential demethylation of hemimethylated CpG or reflect heterogeneity within 
the cell population with at least two subpopulations undergoing demethylation at different 
rates, we compared the theoretical and observed frequencies of the concomitant occurrence of 
unmethylation at various pairs of Cs or combination of three Cs. If the demethylation events 
were independent, the frequency of concomitant occurrence should equal the product of the 
frequencies of the individual events, whereas it should be higher if the events were not 
independent. The hairpin bisulfite data obtained in Fig. 3 following 10 h and 16 h of 
glucocorticoid treatment were analyzed. (A) Expected and observed frequencies of molecules 
demethylated on at least two Cs. For each pair of Cs, the frequency expected for independent 
demethylation events (grey bars) is represented alongside the frequency observed for the 
corresponding event (black bars). Only CpGs #1 to 3 were analyzed because the frequencies 
of the unmethylated Cs at CpG #4 were too low to give rise to significant values. The 
frequencies obtained for two Cs belonging to the same CpG (1 to 3 as indicated) are shown on 
the leftmost part whereas the other part of the histogram shows the frequencies obtained for 
the various pairs of C belonging to distinct CpGs. They are arranged in three groups of four 
pairs, corresponding to each CpG couple (1+2, 2+3 and 1+3 as indicated). Within each group, 
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the two combinations of Cs belonging to the same strand ("same") and the two belonging to 
the opposite strand ("opposite") are displayed. The results reveal that there is a higher than 
expected demethylation of pairs of Cs regardless of the pair that is considered. (B) To test 
whether the bias could be due to a subpopulation of GRU undergoing demethylation at a 
higher rate, we analyzed expected and observed frequencies of molecules demethylated on at 
least three Cs following 10 hours of dexamethasone treatment. To avoid the contribution of a 
putative preferential demethylation of Cs belonging to the same CpG, only combinations of 
Cs belonging to distinct CpGs were analyzed. The striking discrepancy between observed and 
expected frequencies for concerted demethylation of all combinations of three Cs belonging 
to different CpGs indicates that demethylation occurred preferentially within a subpopulation 
of the GRU. This could be due, at least in part, to the population of cells that do not 
demethylate the GRU because they are refractory to glucocorticoid induction when 
undergoing M phase (21). (C, D) Results of a statistical analysis performed with the Fisher’s 
exact tests using contingency tables. Due to the high number of tests performed, the 
significance of the p-values determined by the Fisher’s exact tests was evaluated using the 
sequential Bonferroni technique (Rice, W. R. (1989) Evolution 43, 223-225). The Fisher’s 
exact tests were performed using either of two sets of data: in (C), all data, including the 
sequences that were fully methylated or unmethylated on one residue, and in (D) the 
sequences that were demethylated on at least two residues. The first set of data allows 
evaluation of the significance of concerted demethylation without discriminating if it results 
from demethylation occurring preferentially within a subpopulation of the regulatory 
sequence or from the preferred demethylation of a specific second residue once a first one has 
been demethylated. The second set of data allows testing of the preferred demethylation of a 
specific second residue depending on the first demethylation event without interference with a 
preferred demethylation occurring within a subpopulation. The results are ordered according 
to the p values obtained, indicated in the p(2 tail) column, and the results that are significant 
with a confidence interval of 95% are those which p value is inferior to that determined by the 
sequential Bonferroni technique, indicated in the Bonferroni column, and are indicated in the 
right column. The statistical analyses reveal that, when all demethylation events are 
considered (in C), 7 pairs of Cs show clear statistical significance (p<0.05), 3 of which 
corresponding to pairs of Cs facing each other within the same CpG (3 out of 4 possible 
pairs). The statistical significance is, however, largely due to the preferred demethylation 
within a subpopulation since it is not apparent anymore with the second set of data (in D), 
when the question tested is “Is there preferential demethylation at a second position when a 
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first one is demethylated?”. Thus, we conclude that a preferential demethylation of a MeC 
facing a demethylated C, if it exists at all, contributes only in a minor way to the 
demethylation mechanism. 
 
 
Supplementary Figure 2: Outline of the LM-PCR procedure used in Fig. 1 and 4.  
The LM-PCR was performed to map the 5’-P ends of DNA molecules which were cleaved on 
at least one strand either following chemical treatment specific for unmethylated cytosines 
(39) or during the demethylation process. 
DNA denaturation and primer 1 extension. To one microgram of genomic DNA in 5 µl of 
distilled water (dH2O), 5 µl of 50 mM Tris–HCl pH 8.9, 25 mM MgSO4, 200 mM NaCl, 
100 mg/ml BSA (Buffer 1), 1 µl of primer 1 (0.3 pmol/ml), and 14 µl of dH2O were added. 
The mixture was incubated 5 min at 95°C; then 30 min at 50°C. 1 µl of Buffer 1, 1.2 µl of 
5 mM dNTP, 2.5 µl of dH2O, and 0.25 µl of Vent exo- DNA polymerase (2 u/µl) were added 
and the mixture incubated for 10 min at 50°C and for 20 min at 76°C 
Linker ligation. To the previous mixture 31.6 µl of dH2O, 2.2 µl of 1 M Tris–HCl, pH 7.5, 
0.6 µl of 1 M MgCl2, 1.5 µl of 1 M DTT, 0.4 µl of 10 mg/ml BSA, 0.75 µl of 100 mM ATP, 
3 µl of T4 DNA ligase (1 u/µl) and 5 µl of 20 pmol/µl annealed linker 
(GCGGTGACCCGGGAGATCTGAATTC and GAATTCAGATC in 250 mM Tris–HCl, pH 7.5, 
5mM MgCl2 previously incubated for 5 min at 95°C and for 20 min at room temperature) 
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were added and the mixture was incubated overnight at 17°C. The DNA was then ethanol 
precipitated. 
PCR amplification. The pellet was resuspended in 50 µl of dH2O, then 28.8 µl of dH2O, 
10 µl of 650 mM Tris–HCl, pH 8.8, 100 mM 2-mercaptoethanol, 400 mM NaCl; 10 µl of 
25 mM MgCl2, 8 µl of 5 mM dNTP, 2 µl of primer 2 (5 pmol/ml), 1 µl of 10 mg/ml BSA, 
1 unit of Taq DNA polymerase were added. PCR amplification was performed as follows: 
4 min at 94°C, then 40 s at 94°C, 2 min at 67°C, and 3 min at 76°C for 25 cycles, with a final 
7-min incubation at 76°C.  
Primer and product labelling. 1 µl of primer 3 (12 pmol/ml); 1 µl (20 µCi) of [γ-32P]ATP, 
1 µl of 500 mM Tris–HCl, pH 7.5, 100 mM MgCl2, 50 mM DTT, 1 mM spermidine, 
1 mM EDTA, pH 8 (Buffer 3), 6.5 µl of dH2O, and 0.5 µl of T4 polynucleotide kinase (5 u) 
were mixed and incubated for 30 min at 37°C. Then 15 µl of the previous amplification 
reaction were mixed with 2.5 µl of dH2O, 0.25 µl of the primer labelling reaction, 0.5 µl of 
buffer 3, 0.4 µl of 25 mM MgCl2, 1.5 µl of 5 mM dNTP, and 0.5 unit of Taq DNA 
polymerase. Amplification was as follows: 2 min at 94°C, then 40 s at 94°C, 3 min at 70°C 
and 5 min at 76°C for 5 cycles. The amplified products were ethanol precipitated and loaded 
on a sequencing gel.  
Nucleotide sequence of the primers used: -2500 GRU, lower strand: 
1 AAGTCTCTTCTCAGTGTTC; 2 CAGTGTTCTCTATCACAGGGAGAGC; 
3 TATCACAGGGAGAGCTGTCAGCCCCTG; -2500 GRU, upper strand: 
1 GCCCAAGCTGACCTTGAAC; 2 CACCTCAGCTTCCCAAATGCTGGG; 
3 AGCTTCCCAAATGCTGGGATTACAGGGCT. 
 
 
